Company / Revenue per Share
STANDARD BIOTOOLS INC. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.28
FY2025
5-year range
$0.28 / $1.70
FY2021-FY2025
Trend
-76.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has declined for 3 consecutive years, from $1.70 in FY2022 to $0.28 in FY2025.
Based on SEC 10-K filings.
0.28 in FY2025 with a 5-year CAGR of -29.5%.
Declined from $1.23 to $0.28 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -45.1%
- 5-Year CAGR
- -29.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- STANDARD BIOTOOLS INC.'s revenue per share has declined for 3 consecutive years.
- In FY2025, revenue per share decreased 76.9% year-over-year.
- Peak revenue per share was recorded in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.28 | -76.9% |
| FY2024 | $1.22 | -0.9% |
| FY2023 | $1.23 | -27.4% |
| FY2022 | $1.70 | +7.9% |
| FY2021 | $1.57 | -2.6% |
| FY2020 | $1.61 | -21.8% |
| FY2019 | $2.07 | -23.3% |
| FY2018 | $2.69 | -31.4% |
| FY2017 | $3.93 | -2.7% |
| FY2016 | $4.04 | +60.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026